Dual Diagnosis: Open Access Open Access

  • ISSN: 2472-5048
  • Journal h-index: 5
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Articles published in Dual Diagnosis: Open Access have been cited by esteemed scholars and scientists all around the world. Dual Diagnosis: Open Access has got h-index 5, which means every article in Dual Diagnosis: Open Access has got 5 average citations.

Following are the list of articles that have cited the articles published in Dual Diagnosis: Open Access.

  2021 2020 2019 2018 2017

Year wise published articles

29 16 5 9 7

Year wise citations received

22 17 12 8 10
Journal total citations count 75
Journal h-index 5
Journal h-index since 2016 5
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
Deller J, Perrotte J, Wainwright K, Brunsman J, Osman A (2019) Dimensionality, Reliability, Invariance, and Validity of the Multidimensional Social Anxiety Response Inventory–21 (MSARI–21). Journal of personality assessment  24:1-1.
Nosratabadi M, Halvaiepour Z(2018) The mediating role of emotion regulation in relationship between criticism and cigarette smoking among male adolescents. International Journal of High Risk Behaviors and Addiction.
Dierker L, Braymiller J, Rose J, Goodwin R, Selya A (2018) Nicotine dependence predicts cannabis use disorder symptoms among adolescents and young adults. Drug and alcohol dependence 187:212-20.
Moshe LB, Weizman A, Dor DH, Konas S, Fischel Z, Aizenberg D, et al. (2018) Differences in demographic and clinical characteristics between cannabis users and non-drug users: A retrospective study of patients at first hospitalization due to psychotic symptoms. Psychiatry research  268:454-9.
Roy A, Sh P, Devi KS, Haokip P, Laldinmawii G, Damrolien  (2017) Seroprevalence of hepatitis B and hepatitis C in people who inject drugs and other high risk groups in a tertiary care hospital in Northeast India. International Journal Of Community Medicine And Public Health 4:3306-9.
Chhabra M, Kosey S (2016) SOCIO-DEMOGRAPHIC STUDY OF HEPATITIS C PATIENTS VISITING TERTIARY TEACHING CARE HOSPITAL: AN OBSERVA....
Wilson SM, Puett R, He X, Muhammad EO (2017) PERCEPTIONS OF ENVIRONMENTAL STRESSORS AND BUILDING RESILIENCY IN A COMMUNITY WITH ENVIRONMENTAL JUSTICE ISSUES.
Akefe IO, Adamu AM, Yusuf IL, Anaso EU, Umar MS (2017) Recent Approaches to Toxicity Prevention in Animals.
Magama S, Rants’o T, Asita AO, Taole M (2018) Evaluation of Procavia capensis hyraceum used in traditional medicine for antioxidant activity. Journal of Medicinal Plants Research 12:248-57.
Sum MY, Chew QH, Sim K (2019) Perceptions of the Learning Environment on the Relationship Between Stress and Burnout for Residents in an ACGME-I Accredited National Psychiatry Residency Program. Journal of graduate medical education 11:85-90.
Haile K, Umer H ( 2019) The use of clozapine and clonazepam co-administration in the treatment of a severe tardive dyskinesia: A case report. SAGE open medical case reports 7:2050313X19833254.
Salem H, Pigott T, Zhang XY, Zeni CP, Teixeira AL (2017) Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management. Expert review of neurotherapeutics 17:883-94.
Haile K, Umer H ( 2019) The use of clozapine and clonazepam co-administration in the treatment of a severe tardive dyskinesia: A case report. SAGE open medical case reports 7:2050313X19833254.
Salem H, Pigott T, Zhang XY, Zeni CP, Teixeira AL (2017) Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management. Expert review of neurotherapeutics 17:883-94.
Salem H, Pigott T, Zhang XY, Zeni CP, Teixeira AL (2017) Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management. Expert review of neurotherapeutics 17:883-94.
Busby E, Bold J, Fellows L, Rostami K. (2018) Mood disorders and gluten: it’s not all in your mind! a systematic review with meta-analysis. Nutrients 10: 1708.
McKelvie SJ (2016) Factors in Salt and Pepper Passage: A Further Critical Report on the State of the Art. Psychol Pshycholgy Res Int 1: 000106.
Kiran C, Chaudhury S (2016) Prevalence of comorbid anxiety disorders in schizophrenia. Industrial Psychiatry Journal 25: 35.